世界の経口コレラワクチン市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV08402)
◆英語タイトル:Global Oral Cholera Vaccine Market Insights and Forecast to 2026
◆商品コード:QYR20NV08402
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは経口コレラワクチンの世界市場について調査・分析した資料です。種類別(Shanchol、Dukoral、Vaxchora、その他)の市場規模、用途別(病院、研究所、製薬・バイオテクノロジー企業、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別経口コレラワクチンの競争状況、市場シェア
・世界の経口コレラワクチン市場:種類別市場規模 2015年-2020年(Shanchol、Dukoral、Vaxchora、その他)
・世界の経口コレラワクチン市場:種類別市場規模予測 2021年-2026年(Shanchol、Dukoral、Vaxchora、その他)
・世界の経口コレラワクチン市場:用途別市場規模 2015年-2020年(病院、研究所、製薬・バイオテクノロジー企業、その他)
・世界の経口コレラワクチン市場:用途別市場規模予測 2021年-2026年(病院、研究所、製薬・バイオテクノロジー企業、その他)
・北米の経口コレラワクチン市場分析:米国、カナダ
・ヨーロッパの経口コレラワクチン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの経口コレラワクチン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の経口コレラワクチン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの経口コレラワクチン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):PaxVax、Sanofi、Valneva、EuBiologics
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Oral Cholera Vaccine Market
The global Oral Cholera Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Oral Cholera Vaccine Scope and Market Size
Oral Cholera Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Cholera Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oral Cholera Vaccine market is segmented into
Shanchol
Dukoral
Vaxchora
Others

Segment by Application, the Oral Cholera Vaccine market is segmented into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

Regional and Country-level Analysis
The Oral Cholera Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Cholera Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Cholera Vaccine Market Share Analysis
Oral Cholera Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Cholera Vaccine business, the date to enter into the Oral Cholera Vaccine market, Oral Cholera Vaccine product introduction, recent developments, etc.

The major vendors covered:
PaxVax
Sanofi
Valneva
EuBiologics

【レポートの目次】

1 Study Coverage
1.1 Oral Cholera Vaccine Product Introduction
1.2 Market Segments
1.3 Key Oral Cholera Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Cholera Vaccine Market Size Growth Rate by Type
1.4.2 Shanchol
1.4.3 Dukoral
1.4.4 Vaxchora
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Cholera Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research & Academic Laboratories
1.5.4 Pharmaceutical & Biotechnology Companies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oral Cholera Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Oral Cholera Vaccine Revenue 2015-2026
2.1.2 Global Oral Cholera Vaccine Sales 2015-2026
2.2 Global Oral Cholera Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Cholera Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Cholera Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Oral Cholera Vaccine Competitor Landscape by Players
3.1 Oral Cholera Vaccine Sales by Manufacturers
3.1.1 Oral Cholera Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Oral Cholera Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Cholera Vaccine Revenue by Manufacturers
3.2.1 Oral Cholera Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Oral Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Cholera Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Cholera Vaccine Revenue in 2019
3.2.5 Global Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Cholera Vaccine Price by Manufacturers
3.4 Oral Cholera Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Oral Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Cholera Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Oral Cholera Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Oral Cholera Vaccine Market Size by Type (2015-2020)
4.1.1 Global Oral Cholera Vaccine Sales by Type (2015-2020)
4.1.2 Global Oral Cholera Vaccine Revenue by Type (2015-2020)
4.1.3 Oral Cholera Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Cholera Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Cholera Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Oral Cholera Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Cholera Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Oral Cholera Vaccine Market Size by Application (2015-2020)
5.1.1 Global Oral Cholera Vaccine Sales by Application (2015-2020)
5.1.2 Global Oral Cholera Vaccine Revenue by Application (2015-2020)
5.1.3 Oral Cholera Vaccine Price by Application (2015-2020)
5.2 Oral Cholera Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Cholera Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Cholera Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Oral Cholera Vaccine by Country
6.1.1 North America Oral Cholera Vaccine Sales by Country
6.1.2 North America Oral Cholera Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Cholera Vaccine Market Facts & Figures by Type
6.3 North America Oral Cholera Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe Oral Cholera Vaccine by Country
7.1.1 Europe Oral Cholera Vaccine Sales by Country
7.1.2 Europe Oral Cholera Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Cholera Vaccine Market Facts & Figures by Type
7.3 Europe Oral Cholera Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Oral Cholera Vaccine by Region
8.1.1 Asia Pacific Oral Cholera Vaccine Sales by Region
8.1.2 Asia Pacific Oral Cholera Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Cholera Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Oral Cholera Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Oral Cholera Vaccine by Country
9.1.1 Latin America Oral Cholera Vaccine Sales by Country
9.1.2 Latin America Oral Cholera Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Cholera Vaccine Market Facts & Figures by Type
9.3 Central & South America Oral Cholera Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Oral Cholera Vaccine by Country
10.1.1 Middle East and Africa Oral Cholera Vaccine Sales by Country
10.1.2 Middle East and Africa Oral Cholera Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Cholera Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Oral Cholera Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 PaxVax
11.1.1 PaxVax Corporation Information
11.1.2 PaxVax Description and Business Overview
11.1.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.1.4 PaxVax Oral Cholera Vaccine Products Offered
11.1.5 PaxVax Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Oral Cholera Vaccine Products Offered
11.2.5 Sanofi Related Developments
11.3 Valneva
11.3.1 Valneva Corporation Information
11.3.2 Valneva Description and Business Overview
11.3.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Valneva Oral Cholera Vaccine Products Offered
11.3.5 Valneva Related Developments
11.4 EuBiologics
11.4.1 EuBiologics Corporation Information
11.4.2 EuBiologics Description and Business Overview
11.4.3 EuBiologics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 EuBiologics Oral Cholera Vaccine Products Offered
11.4.5 EuBiologics Related Developments
11.1 PaxVax
11.1.1 PaxVax Corporation Information
11.1.2 PaxVax Description and Business Overview
11.1.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.1.4 PaxVax Oral Cholera Vaccine Products Offered
11.1.5 PaxVax Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Cholera Vaccine Market Estimates and Projections by Region
12.1.1 Global Oral Cholera Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Cholera Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Cholera Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Cholera Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Cholera Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

PaxVax、Sanofi、Valneva、EuBiologics

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の経口コレラワクチン市場2026:インサイト・予測(Global Oral Cholera Vaccine Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。